Gülçin Telli-Dizman

11PUBLICATIONS
78CO-AUTHORS
Epidemiological methodsMedical infection agents (incl. prions)Innate immunityPredictive and prognostic markersIntensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 20, 2026
Safety of discontinuing contact precautions in patients with multidrug-resistant bacterial infection or colonization.

Muhammed Cihan Işık, Gülçin Telli Dizman, Nur Dilek Gül

|Jul 14, 2025
Quantitative Immunoglobulin G and Interferon-Gamma Responses After Different Booster Strategies of CoronaVac and BNT162b2 Vaccines in Türkiye.

Aylin İrem Ocaklı, Şeyma Aybüke Özyar-Kurtçu, Mertcan Uzun

|Jan 13, 2025
Initial Empirical Antibiotic Treatment in Patients with COVID-19 is Associated with Excess Adverse Drug Reactions without Clinical Benefit.

Pınar Bakır Ekinci, Emre Kara, Gülçin Telli Dizman

|Jul 15, 2024
The Impact of Reporting the Same-Day Identification and Antibiotic Susceptibility Test Results on the Treatment of Bloodstream Infections.

Mervenur Demir, Gülçin Telli-Dizman, Gülşen Hazırolan

Pageof 2